Education
About Us
Working with TipRanks
Follow Us
Craig Wheeler Insider Profile
4 Followers
Craig Wheeler, President & CEO, Director at Momenta Pharma, holds 64.22K shares in Amicus (Ticker: FOLD), holds 0.00 shares in Momenta Pharma (Ticker: MNTA), holds 400.39K shares in Avanir Pharmaceuticals (Ticker: AVNR).
Craig Wheeler Momenta Pharma (MNTA)President & CEO, Director
Momenta Pharma (MNTA)
President & CEO, Director
Not Ranked
Craig Wheeler has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Craig Wheeler holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Craig Wheeler
Craig Wheeler's Trading History
Momenta Pharma
Oct 01, 2020
―
Uninformative Sell
―
$0.00
Amicus
Jun 07, 2024
Director
Uninformative Buy
―
$568.96K
Avanir Pharmaceuticals
Feb 14, 2014
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Craig Wheeler's performance on stock
You May Also Like
Craig Wheeler insider profile FAQ
What is the percentage of profitable transactions made by Craig Wheeler?
The percentage of profitable transactions made by Craig Wheeler is ―.
What is the average return per transaction made by Craig Wheeler?
The average return per transaction made by Craig Wheeler is ―.
What stocks does Craig Wheeler hold?
Craig Wheeler holds: MNTA, FOLD, AVNR stocks.
What was Craig Wheeler’s latest transaction?
Craig Wheeler latest transaction was an Uninformative Buy of ―.
What was Craig Wheeler's most profitable transaction?
Craig Wheeler’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Craig Wheeler's role in Momenta Pharma?
Craig Wheeler's role in Momenta Pharma is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.